EssilorLuxottica

EL

FR0000121667

Medical Equipment, Supplies & Distribution

Real-time Euronext Paris Other stock markets 09:12:11 2024-05-17 am EDT			5-day change	1st Jan Change
208.1 ^EUR	+0.82%		+1.07%	+14.59%

May. 16	ESSILORLUXOTTICA : JP Morgan maintains a Buy rating	ZD
May. 07	CAC40: gains altitude, banking sector in support	CF

EssilorLuxottica Société anonyme Names Massimiliano Mutinelli as the New President Optical Retail EMEA

April 15, 2022 at 02:00 am EDT

EssilorLuxottica Société anonyme appointed Massimiliano Mutinelli as the new president optical retail EMEA.

Latest news about EssilorLuxottica

ESSILORLUXOTTICA : JP Morgan maintains a Buy rating	May. 16	ZD
CAC40: gains altitude, banking sector in support	May. 07	CF
Transcript : EssilorLuxottica Société anonyme - Shareholder/Analyst Call	Apr. 30
EssilorLuxottica Société anonyme Approves Final Dividend for the Year Ended on December 31, 2023, Payable on June 3, 2024	Apr. 30	CI
EssilorLuxottica has looked at Marcolin, not seen as strategic, CEO says	Apr. 30	RE
White Pearl Technology Group Bags Digital Marketing Contract from EssilorLuxottica	Apr. 22	MT
ESSILORLUXOTTICA : No major surprises in the Q1	Apr. 19
Global markets live: P&G, Amex, Blackstone, Apple, Tesla...	Apr. 19
ESSILORLUXOTTICA : UBS gives a Neutral rating	Apr. 19	ZD
ESSILORLUXOTTICA : UBS reiterates its recommendation on the stock	Apr. 19	CF
ESSILORLUXOTTICA : Receives a Buy rating from Goldman Sachs	Apr. 19	ZD
ESSILORLUXOTTICA : JP Morgan reiterates its Buy rating	Apr. 19	ZD
EssilorLuxottica Q1 Revenue Rises, Outlook Affirmed	Apr. 18	MT
ESSILORLUXOTTICA : Jefferies remains Neutral	Apr. 18	ZD
ESSILORLUXOTTICA : RBC sticks Neutral	Apr. 18	ZD
Meta releases early versions of its Llama 3 AI model	Apr. 18	RE
ESSILORLUXOTTICA : UBS sticks Neutral	Apr. 18	ZD
EssilorLuxottica Upbeat on Long-Term Outlook After Revenue Increase-- Update	Apr. 18	DJ
EssilorLuxottica Upbeat on Long-Term Outlook After Revenue Increase	Apr. 18	DJ
EssilorLuxottica: confirms sales growth target	Apr. 18	CF
Transcript : EssilorLuxottica Société anonyme, Q1 2024 Sales/ Trading Statement Call, Apr 18, 2024	Apr. 18
Ray-Ban maker EssilorLuxottica's revenues rose 5.5% in first quarter	Apr. 18	RE
Global markets live: DocMorris, Microsoft, Oracle, Micron, Netflix...	Apr. 18
EssilorLuxottica Announces Revenue Results for the First Quarter of 2024	Apr. 18	CI
Meta releases early versions of its Llama 3 AI model	Apr. 18	RE

EssilorLuxottica is a global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. Formed in 2018, the company brings together the complementary expertise of two industry pioneers, one in advanced lens technology and the other in the craftsmanship of iconic eyewear, to set new industry standards for vision care and the consumer experience around it. Influential eyewear brands including Ray-Ban and Oakley, lens technology brands including Varilux® and Transitions®, and world-class retail brands including Sunglass Hut and LensCrafters are part of the EssilorLuxottica family.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-07-24 - Q2 2024 Earnings Release

Related indices

CAC 40 , EURO STOXX 50 , STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

ESSILORLUXOTTICA : No major surprises in the Q1

April 19, 2024 at 10:12 am EDT

More Strategies

Ratings for EssilorLuxottica

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

206.4 EUR

Average target price

205.9 EUR

Spread / Average Target

-0.24%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Glasses, Spectacles & Contact Lenses

	1st Jan change	Capi.
ESSILORLUXOTTICA	+14.59%	101B
ALCON INC.	+21.18%	44.19B
THE COOPER COMPANIES, INC.	+3.48%	19.46B
AUTEK CHINA INC.	-17.76%	2.31B
WARBY PARKER INC.	+14.54%	1.92B
PEGAVISION CORPORATION	+28.37%	1.23B
MINGYUE OPTICAL LENS CO.,LTD.	-35.09%	755M
MENICON CO., LTD.	-40.97%	699M
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD.	-7.22%	677M
VIZIONFOCUS INC.	+26.26%	510M

Glasses, Spectacles & Contact Lenses